Trial Outcomes & Findings for Assessment of Limb Perfusion During Junctional Tourniquet (NCT NCT02092415)

NCT ID: NCT02092415

Last Updated: 2015-05-29

Results Overview

Contrast ultrasound perfusion imaging will be performed at baseline and 1 min after application of the JT.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

10 participants

Primary outcome timeframe

baseline and 1 min post occlusion

Results posted on

2015-05-29

Participant Flow

Participant milestones

Participant milestones
Measure
Normal Subjects
Normal subjects, all of whom undergo brief application of junctional tourniquet Application of a Junctional Tourniquet: All subjects will be studied at baseline and after placement of a junctional tourniquet to the femoral artery.
Overall Study
STARTED
10
Overall Study
COMPLETED
10
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Assessment of Limb Perfusion During Junctional Tourniquet

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Normal Subjects
n=10 Participants
Normal subjects, all of whom undergo brief application of junctional tourniquet Application of a Junctional Tourniquet: All subjects will be studied at baseline and after placement of a junctional tourniquet to the femoral artery.
Age, Categorical
<=18 years
0 Participants
n=93 Participants
Age, Categorical
Between 18 and 65 years
10 Participants
n=93 Participants
Age, Categorical
>=65 years
0 Participants
n=93 Participants
Sex: Female, Male
Female
5 Participants
n=93 Participants
Sex: Female, Male
Male
5 Participants
n=93 Participants
Region of Enrollment
United States
10 participants
n=93 Participants

PRIMARY outcome

Timeframe: baseline and 1 min post occlusion

Contrast ultrasound perfusion imaging will be performed at baseline and 1 min after application of the JT.

Outcome measures

Outcome measures
Measure
Normal Subjects Baseline Flow
n=10 Participants
Normal subjects, all of whom undergo brief application of junctional tourniquet Application of a Junctional Tourniquet: All subjects will be studied at baseline and after placement of a junctional tourniquet to the femoral artery.
Normal Subjects - Tourniquet Flow
n=10 Participants
Perfusion measured at time of tourniquet placement
Muscle Perfusion
0.32 IU/s
Standard Error 0.10
0.10 IU/s
Standard Error 0.03

Adverse Events

Normal Subjects

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Jonathan Lindner MD

Oregon Health & Science University

Phone: 503 595-8750

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place